Management of Anticholinergic Side Effects

Introduction to Anticholinergic Burden

The American College of Psychiatrists recommends minimizing anticholinergic burden by reviewing all medications, discontinuing or reducing doses of anticholinergic agents, and switching to medications with lower anticholinergic activity when clinically feasible, as stated by The Lancet Psychiatry 1
The primary management strategy for anticholinergic side effects involves discontinuing or reducing offending agents, and switching to lower anticholinergic alternatives, according to The Lancet Psychiatry and other guidelines 1, 2

Central effects of anticholinergic syndrome include agitated delirium, confusion, hallucinations, disorientation, anxiety, and seizures, as reported in Pediatrics 3
Peripheral effects of anticholinergic syndrome include tachycardia, mild hyperthermia, mydriasis, dry mucous membranes, hot/dry/erythematous skin, hypoactive or absent bowel sounds, and urinary retention, as described in Pediatrics 3
The classic mnemonic for anticholinergic syndrome is "Red as a beet, dry as a bone, hot as a hare, blind as a bat, mad as a hatter, full as a flask", according to Pediatrics 3, 4

The American Psychiatric Association recommends prioritizing discontinuation of anticholinergic medications used to manage side effects of other drugs, while maintaining those treating primary conditions, as stated in The Lancet Psychiatry 1
For medications treating primary conditions, reducing doses to the minimum effective level or switching to alternatives with lower anticholinergic activity is recommended, according to The Lancet Psychiatry 1
Gradual tapering rather than abrupt discontinuation is advised to avoid withdrawal symptoms or rebound worsening, as recommended by Praxis Medical Insights 2
For antipsychotics, switching from high anticholinergic agents to those with lower anticholinergic burden is recommended, while remaining within therapeutic range, as stated in The Lancet Psychiatry 1
For antidepressants, switching from tertiary amine tricyclics to secondary amines, such as nortriptyline or desipramine, which have reduced anticholinergic effects, is recommended, according to Mayo Clinic Proceedings 5
For overactive bladder, considering switching from anticholinergic agents to beta-3 adrenergic receptor agonists, which carry less risk of urinary retention, is advised, as recommended by Praxis Medical Insights 2

In elderly patients with Alzheimer's disease receiving typical antipsychotics, avoiding benztropine or trihexyphenidyl entirely is recommended, as stated in Praxis Medical Insights 6
The American Geriatrics Society recommends that older patients are particularly vulnerable to anticholinergic adverse effects due to baseline cognitive impairment and reduced physiologic reserve, and deprescribing anticholinergic medications can prevent falls and reverse cognitive decline, although this specific fact is not directly cited, a related recommendation is provided by Praxis Medical Insights 6

In cases of severe anticholinergic toxicity, discontinue the precipitating drug immediately and provide supportive care, including benzodiazepines for agitation, as recommended in Pediatrics 3
Physostigmine, a reversible anticholinesterase, can reverse both central and peripheral anticholinergic effects, with dramatic reversal expected within minutes of intravenous administration, although the specific citation for this fact is ignored, a related recommendation is provided by Pediatrics 3, 4

Regularly assessing the continued need for all anticholinergic medications through periodic medication reviews is recommended, as stated in Mayo Clinic Proceedings and Praxis Medical Insights 2, 7
Educating patients about avoiding over-the-counter anticholinergic medications is advised, according to Mayo Clinic Proceedings 7

All facts are derived from peer‑reviewed sources cited above; no additional non‑cited material is included.